Skip to main content

Loumeau Eric J's Form 4 filing

Anaptysbio, Inc (ANAB) · filed Sep 18, 2023

Accession no.
0001209191-23-049809
Filed
Sep 18, 2023
Trade date
Sep 14-18, 2023
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $116.3K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Loumeau Eric JCIK 0001239648Officer (Chief Legal Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 14, 2023Common StockMOption exerciseAcquired+6,000––6,882Direct
Sep 14, 2023Common StockSSaleDisposed−2,105$19.48−$41,005.44,777Direct
Sep 18, 2023Common StockSSaleDisposed−3,895$19.32−$75,251.4882Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 14, 2023Common StockMOption exerciseDisposed−6,000$0.00$06,000Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)